Pacer Advisors
IMGN

Pacer Advisors’s Immunogen Inc IMGN Stock Holding History

Pacer Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,846
Closed -$72K – 1581
2021
Q1 		$72K Sell
8,846
-2,440
-22% -$19.9K ﹤0.01% 1363
2020
Q4 		$73K Buy
11,286
+148
+1% +$863 ﹤0.01% 1390
2020
Q3 		$40K Buy
+11,138
New +$45K ﹤0.01% 1312
2018
Q4 		– Sell
-22,520
Closed -$213K – 1091
2018
Q3 		$213K Buy
+22,520
New +$216K 0.01% 1025
2018
Q1 		– Sell
-6,532
Closed -$42K – 1136
2017
Q4 		$42K Buy
+6,532
New +$40.3K ﹤0.01% 1037

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Pacer Advisors's IMGN Position: Q2 2021 in Review

Pacer Advisors sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 8,846 shares — an estimated $72K sold.

Pacer Advisors first reported a position in IMGN in Q4 2017 and held it in 5 quarters. The position peaked at $213K in Q3 2018. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

  • Pacer Advisors reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 8,846 Immunogen Inc shares in Q2 2021, an estimated $72K.
  • Pacer Advisors first reported a position in Immunogen Inc in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's Immunogen Inc position peaked at $213K in Q3 2018.
  • 214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.